Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Longitudinal changes in pancreatic neuroendocrine tumor (panNET) cell proliferation correlate with fast disease progression and poor prognosis. The optimal treatment strategy for secondary panNET grade (G)3 that has progressed from a previous low-or intermediate-grade to high-grade panNET G3 is curr...

Full description

Bibliographic Details
Main Authors: Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias Åkerström, Barbro Eriksson, Staffan Welin, Anders Sundin, Joakim Crona
Format: Article
Language:English
Published: Bioscientifica 2022-03-01
Series:Endocrine Connections
Subjects:
pancreatic neuroendocrine tumor
highgrade
systemic therapy
treatment outcomes
Online Access:https://ec.bioscientifica.com/view/journals/ec/11/3/EC-21-0604.xml

Similar Items

Similar Items